Literature DB >> 29778257

Localized US Efforts to Eliminate Hepatitis C.

Annette Gaudino1, Bryn Gay1, Clifton Garmon2, Mike Selick3, Reed Vreeland4, Katie Burk5, Emalie Huriaux6, Shelley N Facente7, Annie Luetkemeyer8, Phil Waters9, Camilla S Graham10.   

Abstract

The United States has national plans for the elimination of hepatitis C virus but much of US health care is organized on the state level and requires local solutions. This article describes the plans developed by New York, Massachusetts, and the city/county of San Francisco for hepatitis C virus elimination. Coalitions capitalize on existing resources and advocate for new resources to address barriers in hepatitis C virus care. Although each coalition has distinct plans, all share a commitment to groups that are disproportionately affected and are at risk for being excluded from advances in hepatitis C virus treatment and cure.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advocacy; Coalition; Continuum of care; Elimination; Hepatitis C virus; Legal; People who inject drugs

Mesh:

Substances:

Year:  2018        PMID: 29778257     DOI: 10.1016/j.idc.2018.02.009

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  8 in total

1.  Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019.

Authors:  Shelley N Facente; Rachel Grinstein; Roberta Bruhn; Zhanna Kaidarova; Erin Wilson; Jennifer Hecht; Katie Burk; Eduard Grebe; Meghan D Morris
Journal:  PLoS One       Date:  2022-05-11       Impact factor: 3.752

2.  Hepatitis C mortality trends in San Francisco: can we reach elimination targets?

Authors:  Ali Mirzazadeh; Shelley N Facente; Katie Burk; James G Kahn; Meghan D Morris
Journal:  Ann Epidemiol       Date:  2021-10-23       Impact factor: 6.996

3.  Hepatitis C Elimination During a Global Pandemic: A Case Study of Resilience in Action.

Authors:  Shelley N Facente; Rachel Grinstein; Janessa Broussard; Jessica Shost; Soraya Azari; Jennifer Siruno; Jose A Jimenez; Anne F Luetkemeyer; Katie Burk
Journal:  Public Health Rep       Date:  2022-04-09       Impact factor: 3.117

4.  Hepatitis C Care Cascades for 3 Populations at High Risk: Low-income Trans Women, Young People Who Inject Drugs, and Men Who Have Sex With Men and Inject Drugs.

Authors:  Shelley N Facente; Sheena Patel; Jennifer Hecht; Erin Wilson; Willi McFarland; Kimberly Page; Peter Vickerman; Hannah Fraser; Katie Burk; Meghan D Morris
Journal:  Clin Infect Dis       Date:  2021-09-15       Impact factor: 9.079

5.  A Digital Case-Finding Algorithm for Diagnosed but Untreated Hepatitis C: A Tool for Increasing Linkage to Treatment and Cure.

Authors:  Brooke Wyatt; Ponni V Perumalswami; Anna Mageras; Mark Miller; Alyson Harty; Ning Ma; Chip A Bowman; Francina Collado; Jihae Jeon; Lismeiry Paulino; Amreen Dinani; Douglas Dieterich; Li Li; Maxence Vandromme; Andrea D Branch
Journal:  Hepatology       Date:  2021-12       Impact factor: 17.298

6.  Do patients at high risk for Hepatitis C receive recommended testing? A retrospective cohort study of statewide Medicaid claims linked with OneFlorida clinical data.

Authors:  Rahma S Mkuu; Elizabeth A Shenkman; Keith E Muller; Tianyao Huo; Ramzi G Salloum; Roniel Cabrera; Ali Zarrinpar; Emmanuel Thomas; Sarah M Szurek; David R Nelson
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

Review 7.  Innovations in Hepatitis C Screening and Treatment.

Authors:  Arpan A Patel; Aileen Bui; Eian Prohl; Debika Bhattacharya; Su Wang; Andrea D Branch; Ponni V Perumalswami
Journal:  Hepatol Commun       Date:  2020-12-07

Review 8.  Cancer health disparities in racial/ethnic minorities in the United States.

Authors:  Valentina A Zavala; Paige M Bracci; John M Carethers; Luis Carvajal-Carmona; Nicole B Coggins; Marcia R Cruz-Correa; Melissa Davis; Adam J de Smith; Julie Dutil; Jane C Figueiredo; Rena Fox; Kristi D Graves; Scarlett Lin Gomez; Andrea Llera; Susan L Neuhausen; Lisa Newman; Tung Nguyen; Julie R Palmer; Nynikka R Palmer; Eliseo J Pérez-Stable; Sorbarikor Piawah; Erik J Rodriquez; María Carolina Sanabria-Salas; Stephanie L Schmit; Silvia J Serrano-Gomez; Mariana C Stern; Jeffrey Weitzel; Jun J Yang; Jovanny Zabaleta; Elad Ziv; Laura Fejerman
Journal:  Br J Cancer       Date:  2020-09-09       Impact factor: 9.075

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.